This website is intended for healthcare professionals only.
Newsletter
MENU
MENU
News
Covid-19
Clinical
Allergy
Emergency and critical care
Gastroenterology
Respiratory
Cardiovascular
Oncology/Haematology
Radiology and Imaging
Rheumatology
Educational resources
Issues
2021
2020
2019
2018
2017
2016
Sponsored
MENU
MENU
News
Covid-19
Clinical
Allergy
Emergency and critical care
Gastroenterology
Respiratory
Cardiovascular
Oncology/Haematology
Radiology and Imaging
Rheumatology
Educational resources
Issues
2021
2020
2019
2018
2017
2016
Sponsored
Skyrizi receives MHRA approval for psoriatic arthritis
Xevudy (sotrovimab) approved by MHRA for mild to moderate COVID-19
RAAS inhibition reduces COVID-19 mortality within intensive care
News
Xevudy (sotrovimab) approved by MHRA for mild to moderate COVID-19
RAAS inhibition reduces COVID-19 mortality within intensive care
Sponsored
Albumin
Clinical
Button battery ingestion in children: A growing problem
RAAS inhibition reduces COVID-19 mortality within intensive care
Analysis shows skin peanut allergy patch safe and well tolerated over 3-year period
Latest issue
Sponsored: The benefits of working with the global leader in diagnostics to support the diagnosis of allergic and autoimmune diseases
How to assess systemic lupus erythematosus in clinical care
Supplements
Previous
Next
Popular articles
Comirnaty COVID-19 vaccine approved by EMA for children aged 5 – 11
30 November, 2021
Aspirin use linked to increased risk of heart failure
29 November, 2021
Metformin use in pre-diabetics with a BMI > 35 reduced incident cardiovascular disease
29 November, 2021
Total bile acid concentration a possible biomarker for coronary artery disease
29 November, 2021
Sacubitril-valsartan provides no mortality benefit compared with ramipril in acute MI with reduced ejection fraction
26 November, 2021
